Tatiana Kent

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Acute Lymphoblastic Leukemia

Epstein Barr Virus

Endothelial Cells

Top Venues

RNA (New York, N.Y.)

Science advances

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Marissa L Calbert, Gurushankar Chandramouly, Clare M Adams, Magali Saez-Ayala, Tatiana Kent, Mrityunjay Tyagi, V S S Abhinav Ayyadevara, Yifan Wang, John J Krais, John Gordon, Jessica Atkins, Monika Maria Toma, Stéphane Betzi, Andrew S Boghossian, Matthew G Rees, Melissa A Ronan, Jennifer A Roth, Aaron R Goldman, Nicole Gorman, Ramkrishna Mitra, Wayne E Childers, Xavier Graña, Tomasz Skorski, Neil Johnson, Christian Hurtz, Xavier Morelli, Christine M Eischen, Richard T Pomerantz
4'-Ethynyl-2'-Deoxycytidine (EdC) Preferentially Targets Lymphoma and Leukemia Subtypes by Inducing Replicative Stress. Molecular cancer therapeutics (2023)
Taylor N Tredinnick, Tatiana Kent, Leonid Minakhin, Ziyuan Li, Jozef Madzo, Xiaojiang S Chen, Richard T Pomerantz
Promoter-Independent Synthesis of Chemically Modified RNA by Polymerase θ Variants. RNA (New York, N.Y.) (2023)
Gurushankar Chandramouly, Jiemin Zhao, Shane McDevitt, Timur Rusanov, Trung Hoang, Nikita Borisonnik, Taylor N Tredinnick, Felicia Wednesday Lopezcolorado, Tatiana Kent, Labiba A Siddique, Joseph Mallon, Jacklyn Huhn, Zainab Shoda, Ekaterina Kashkina, Alessandra Brambati, Jeremy M Stark, Xiaojiang S Chen, Richard T Pomerantz
Polθ reverse transcribes RNA and promotes RNA-templated DNA repair. Science advances 7 (24) (2021)